Výsledky vyhledávání - "Marine Pascal Pingeon"

Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples

Autor: Albino Coglianese, Luigi Marino, Amelia Filippelli, Carmine Selleri, Fabrizio Dal Piaz, Marine Pascal Pingeon, Bruno Charlier, Viviana Izzo, Barbara Izzo, Bianca Serio

Publikováno v: Analytical Letters. 52:1328-1339

Ruxolitinib is a JAK 1/2 inhibitor approved in 2011 by the Food and Drug Administration (FDA) for the treatment of patients with myelofibrosis. Currently, side effects related to the use of ruxolit...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::166ba23b18a697d6fc54a968712c783d
https://doi.org/10.1080/00032719.2018.1537283

Zobrazit plný text záznamu

Plný text ve formátu HTML

A UHPLC–MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers

Autor: Marine Pascal Pingeon, Maria Alfieri, Valeria Conti, Valentina Manzo, Alfonso Vietri, Fabrizio Dal Piaz, Bruno Charlier, Antonietta Finelli, Marianna Romano, Viviana Izzo, Amelia Filippelli, Elena Bloise

Publikováno v: Journal of Pharmaceutical and Biomedical Analysis. 154:245-251

Exposure of healthcare workers to anticancer drugs requires the combined action of environmental and biological monitoring to assess the effective level of exposure to these chemicals, to improve awareness and to avoid adverse health effects on this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0058e45f471d2ebf59eb1822e5ccde01
https://doi.org/10.1016/j.jpba.2018.03.024

Zobrazit plný text záznamu

Novel Drug Targets for the Treatment of Cardiac Diseases

Autor: Viviana Izzo, Francesca Mensitieri, Marine Pascal Pingeon, Bruno Charlier, Fabrizio Dal Piaz, Federica De Lise

Publikováno v: Current Pharmacogenomics and Personalized Medicine. 15

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb6a6c3f15ae99ec01ac96a8227b747
https://doi.org/10.2174/1875692115666170503105402

Zobrazit plný text záznamu

Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease

Autor: F. Dal Piaz, Bruno Charlier, Amelia Filippelli, Ilenia Pantano, L. Pierro, Serena Fasano, Michele Iudici, Viviana Izzo, Marine Pascal Pingeon

Background/objective The objectives of this paper are to assess the extent of and the factors associated with hydroxychloroquine (HCQ) non-adherence in systemic lupus erythematosus (SLE) patients with prolonged inactive disease and to investigate rel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0567f2ef85cc81d88bf69340a9db6617
http://hdl.handle.net/11386/4687898

Zobrazit plný text záznamu

Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood

Autor: Gabriele Valentini, Marine Pascal Pingeon, Bruno Charlier, Valeria Conti, Amelia Filippelli, Viviana Izzo, Fabrizio Dal Piaz

Publikováno v: Biomedical Chromatography. 32:e4258

Hydroxychloroquine (HCQ) is an old antimalarial drug that has proven to be a safe and effective treatment for systemic lupus erythematosus (SLE) and other autoimmune diseases. Since hematic concentration of HCQ is closely related to the therapeutic r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3a75c199e3b1901c9ab2fa815398af
https://doi.org/10.1002/bmc.4258

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání